Cipla | CIPLA - Current Assets


Cipla reported INR241.47B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Arca Biopharma USD 395.25M 51.39M Mar/2026
aTyr Pharma USD 67.58M 178.23M Mar/2026
Bio Path USD 677K 14K Mar/2026
Brainstorm Cell Therapeutics USD 184K 123K Mar/2026
Capricor Therapeutics USD 283.09M 39.85M Mar/2026
Cara Therapeutics USD 31.54M 6.9M Dec/2025
Cipla INR 241.47B 7.71B Mar/2026
Dr.Reddys Laboratories INR 301.79B 4.24B Mar/2026
Esperion Therapeutics USD 459.46M 3.11M Mar/2026
Immunic USD 188.76M 165.89M Mar/2026
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sun Pharmaceuticals INR 638.6B 37.24B Mar/2026
TherapeuticsMD USD 11.82M 303K Jun/2024
UPL INR 422.95B 9.97B Mar/2026